The global microfluidics market size is estimated at USD 30.66 billion in 2025 and is predicted to reach around USD 110.40 billion by 2034, accelerating at a CAGR of 15.30% from 2025 to 2034. The North America microfluidics market size surpassed USD 11.47 billion in 2024 and is expanding at a CAGR of 15.31% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
7.1. Microfluidics Market, by Material Type
7.1.1. Glass
7.1.1.1. Market Revenue and Forecast
7.1.2. Silicon
7.1.2.1. Market Revenue and Forecast
7.1.3. PDMS
7.1.3.1. Market Revenue and Forecast
7.1.4. Polymers
7.1.4.1. Market Revenue and Forecast
7.1.5. Others
7.1.5.1. Market Revenue and Forecast
8.1. Microfluidics Market, by Application
8.1.1. Organs-on-chips
8.1.1.1. Market Revenue and Forecast
8.1.2. Lab-on-a-chip
8.1.2.1. Market Revenue and Forecast
8.1.3. Continuous Flow Microfluidics
8.1.3.1. Market Revenue and Forecast
8.1.4. Acoustofluidics and Microfluidics
8.1.4.1. Market Revenue and Forecast
8.1.5. Optofluidics and Microfluidics
8.1.5.1. Market Revenue and Forecast
8.1.6. Electrophoresis and Microfluidics
8.1.6.1. Market Revenue and Forecast
9.1. Microfluidics Market, by Technology
9.1.1. Non-Medical
9.1.1.1. Market Revenue and Forecast
9.1.2. Medical (Gel Electrophoresis, PCR & RT-PCR, ELISA, Microarrays, Others)
9.1.2.1. Market Revenue and Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Material
10.1.2. Market Revenue and Forecast, by Application
10.1.3. Market Revenue and Forecast, by Technology
10.1.4. U.S.
10.1.4.1. Market Revenue and Forecast, by Material
10.1.4.2. Market Revenue and Forecast, by Application
10.1.4.3. Market Revenue and Forecast, by Technology
10.1.5. Rest of North America
10.1.5.1. Market Revenue and Forecast, by Material
10.1.5.2. Market Revenue and Forecast, by Application
10.1.5.3. Market Revenue and Forecast, by Technology
10.2. Europe
10.2.1. Market Revenue and Forecast, by Material
10.2.2. Market Revenue and Forecast, by Application
10.2.3. Market Revenue and Forecast, by Technology
10.2.4. UK
10.2.4.1. Market Revenue and Forecast, by Material
10.2.4.2. Market Revenue and Forecast, by Application
10.2.4.3. Market Revenue and Forecast, by Technology
10.2.5. Germany
10.2.5.1. Market Revenue and Forecast, by Material
10.2.5.2. Market Revenue and Forecast, by Application
10.2.5.3. Market Revenue and Forecast, by Technology
10.2.6. France
10.2.6.1. Market Revenue and Forecast, by Material
10.2.6.2. Market Revenue and Forecast, by Application
10.2.6.3. Market Revenue and Forecast, by Technology
10.2.7. Rest of Europe
10.2.7.1. Market Revenue and Forecast, by Material
10.2.7.2. Market Revenue and Forecast, by Application
10.2.7.3. Market Revenue and Forecast, by Technology
10.3. APAC
10.3.1. Market Revenue and Forecast, by Material
10.3.2. Market Revenue and Forecast, by Application
10.3.3. Market Revenue and Forecast, by Technology
10.3.4. India
10.3.4.1. Market Revenue and Forecast, by Material
10.3.4.2. Market Revenue and Forecast, by Application
10.3.4.3. Market Revenue and Forecast, by Technology
10.3.5. China
10.3.5.1. Market Revenue and Forecast, by Material
10.3.5.2. Market Revenue and Forecast, by Application
10.3.5.3. Market Revenue and Forecast, by Technology
10.3.6. Japan
10.3.6.1. Market Revenue and Forecast, by Material
10.3.6.2. Market Revenue and Forecast, by Application
10.3.6.3. Market Revenue and Forecast, by Technology
10.3.7. Rest of APAC
10.3.7.1. Market Revenue and Forecast, by Material
10.3.7.2. Market Revenue and Forecast, by Application
10.3.7.3. Market Revenue and Forecast, by Technology
10.4. MEA
10.4.1. Market Revenue and Forecast, by Material
10.4.2. Market Revenue and Forecast, by Application
10.4.3. Market Revenue and Forecast, by Technology
10.4.4. GCC
10.4.4.1. Market Revenue and Forecast, by Material
10.4.4.2. Market Revenue and Forecast, by Application
10.4.4.3. Market Revenue and Forecast, by Technology
10.4.5. North Africa
10.4.5.1. Market Revenue and Forecast, by Material
10.4.5.2. Market Revenue and Forecast, by Application
10.4.5.3. Market Revenue and Forecast, by Technology
10.4.6. South Africa
10.4.6.1. Market Revenue and Forecast, by Material
10.4.6.2. Market Revenue and Forecast, by Application
10.4.6.3. Market Revenue and Forecast, by Technology
10.4.7. Rest of MEA
10.4.7.1. Market Revenue and Forecast, by Material
10.4.7.2. Market Revenue and Forecast, by Application
10.4.7.3. Market Revenue and Forecast, by Technology
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Material
10.5.2. Market Revenue and Forecast, by Application
10.5.3. Market Revenue and Forecast, by Technology
10.5.4. Brazil
10.5.4.1. Market Revenue and Forecast, by Material
10.5.4.2. Market Revenue and Forecast, by Application
10.5.4.3. Market Revenue and Forecast, by Technology
10.5.5. Rest of LATAM
10.5.5.1. Market Revenue and Forecast, by Material
10.5.5.2. Market Revenue and Forecast, by Application
10.5.5.3. Market Revenue and Forecast, by Technology
11.1. Agilent Technologies, Inc.
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Illumina, Inc.
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Perkinelmer, Inc.
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Life Technologies Corporation
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Danaher
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Bio-Rad Laboratories, Inc.
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Hoffmann-La Roche Ltd
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Abbott Laboratories
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Fluidigm Corporation
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Qiagen N.V.
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
11.11. Thermo Fischer Scientific
11.11.1. Company Overview
11.11.2. Product Offerings
11.11.3. Financial Performance
11.11.4. Recent Initiatives
11.12. Biomérieux
11.12.1. Company Overview
11.12.2. Product Offerings
11.12.3. Financial Performance
11.12.4. Recent Initiatives
11.13. Cellix Ltd.
11.13.1. Company Overview
11.13.2. Product Offerings
11.13.3. Financial Performance
11.13.4. Recent Initiatives
11.14. Elveflow
11.14.1. Company Overview
11.14.2. Product Offerings
11.14.3. Financial Performance
11.14.4. Recent Initiatives
11.15. Micronit Micro Technologies B.V.
11.15.1. Company Overview
11.15.2. Product Offerings
11.15.3. Financial Performance
11.15.4. Recent Initiatives
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
13.1. About Us
13.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client